Improving the Developability of Biopharmaceuticals

Attana and Lonza in collaboration:
The combination of computational and protein engineering tools with novel orthogonal methods of measuring aggregation can be used to assess the developability of biopharm products in the early stages of development, thereby reducing the level of risk in later stages.